Quick Answer
NORTHWEST BIOTHERAPEUTICS INC reported Operating Income of -$66.51 million for fiscal year 2024.
NORTHWEST BIOTHERAPEUTICS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$66.51M | -19.8% |
| 2023 | -$55.51M | +17.4% |
| 2022 | -$67.18M | -27.5% |
| 2021 | -$52.70M | +39.1% |
| 2020 | -$86.61M | -209.5% |
| 2019 | -$27.98M | +32.5% |
| 2018 | -$41.48M | +24.1% |
| 2017 | -$54.68M | +31.0% |
| 2016 | -$79.27M | +37.2% |
| 2015 | -$126.28M | -24.9% |
| 2014 | -$101.14M | -82.3% |
| 2013 | -$55.47M | -26.6% |
| 2012 | -$43.83M | -63.6% |
| 2011 | -$26.79M | -74.5% |
| 2010 | -$15.35M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.32M | +3.2% | +3.1% |
| June 30, 2025 | -$14.78M | +15.4% | +14.6% |
| March 31, 2025 | -$17.31M | -10.0% | -17.0% |
| September 30, 2024 | -$14.80M | -7.1% | +15.2% |
| June 30, 2024 | -$17.46M | -28.6% | -10.9% |
| March 31, 2024 | -$15.74M | -21.4% | -13.9% |
| September 30, 2023 | -$13.82M | +11.5% | -1.8% |
| June 30, 2023 | -$13.58M | +35.7% | -4.7% |
- NORTHWEST BIOTHERAPEUTICS INC showed a decrease of -19.8% in Operating Income compared to the prior fiscal year.
- Over the 2010–2024 period, NORTHWEST BIOTHERAPEUTICS INC’s operating income has declined by 333.2% (from -$15.35 million to -$66.51 million).
- The most recent figure is from NORTHWEST BIOTHERAPEUTICS INC’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: